Matthew Kawa Gets 5 Years 10 Months for Selling 54,000 Mislabeled Supplements
Updated
Updated · bbc.co.uk · Jul 31
Matthew Kawa Gets 5 Years 10 Months for Selling 54,000 Mislabeled Supplements
3 articles · Updated · bbc.co.uk · Jul 31
Summary
A US court jailed Paradigm Peptides owner Matthew Kawa for five years and 10 months after he admitted selling unapproved medicines, mislabeling them as supplements and illegally importing them.
Jennifer Stechkober, Kawa’s sister, received one year and four months after both admitted lying about sourcing, purity and testing, while products marketed as US-made were imported from China, India and elsewhere.
FDA testing found Paradigm’s SARMs products were mixed with testosterone, despite the company’s claims of 99% purity and stringent analysis; prosecutors said the business had ignored warning letters dating back to 2020.
The case covers 54,000 consumers worldwide. One Tennessee customer said the tainted pills triggered steroid-induced psychosis, and 167 victims have sought $78,317 in compensation for harms including blood clots, heart issues, anxiety and depression.
The prosecution has become a landmark case for the fast-growing, lightly regulated online peptides and SARMs market, where products are sold globally despite not being approved for human use.
If unapproved muscle and weight-loss peptides are labeled for research only, who holds the ultimate liability when buyers suffer severe psychiatric harm?
With FDA warnings taking years to enforce, how many more consumers will fall victim to forged lab certificates on popular online health supplements?